1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for SGHT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2022. Start Trial.
Date Value
September 28, 2026 166.4%
September 25, 2026 160.3%
September 24, 2026 145.2%
September 23, 2026 141.5%
September 22, 2026 139.3%
September 21, 2026 135.8%
September 18, 2026 117.3%
September 17, 2026 136.3%
September 16, 2026 133.2%
September 15, 2026 130.4%
September 14, 2026 135.0%
September 11, 2026 124.9%
September 10, 2026 134.8%
September 09, 2026 125.5%
September 08, 2026 119.5%
September 04, 2026 123.9%
September 03, 2026 120.5%
September 02, 2026 117.6%
September 01, 2026 101.7%
August 31, 2026 109.4%
August 28, 2026 111.6%
August 27, 2026 98.82%
August 26, 2026 97.87%
August 25, 2026 97.62%
August 24, 2026 98.11%
Date Value
August 21, 2026 100.5%
August 20, 2026 100.2%
August 19, 2026 107.1%
August 18, 2026 96.18%
August 17, 2026 96.19%
August 14, 2026 91.53%
August 13, 2026 95.76%
August 12, 2026 94.82%
August 11, 2026 88.11%
August 10, 2026 81.60%
August 07, 2026 110.4%
August 06, 2026 92.66%
August 05, 2026 59.03%
August 04, 2026 62.54%
August 03, 2026 69.11%
July 31, 2026 57.96%
July 30, 2026 52.46%
July 29, 2026 54.34%
July 28, 2026 49.72%
July 27, 2026 46.70%
July 24, 2026 37.92%
July 23, 2026 24.34%
July 22, 2026 40.90%
July 21, 2026 43.15%
July 20, 2026 44.00%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Integra LifeSciences Holdings Corp. 23.26%
Abbott Laboratories -22.64%
AngioDynamics, Inc. 45.51%
Alphatec Holdings, Inc. -33.09%
AtriCure, Inc. 65.94%